arrow_back Back to App

September 2025: Polycystic Kidney Disease Awareness Month – Support and Education

This House Resolution supports designating September 2025 as National Polycystic Kidney Disease Awareness Month. The goal is to boost public understanding of this genetic disorder, which affects approximately 600,000 Americans, and to highlight the critical need for more research into treatments and a cure. Citizens are encouraged to participate in educational activities, which can help them better grasp the disease and its daily impact.
Key points
Raising public awareness about Polycystic Kidney Disease (PKD), a leading cause of kidney failure.
Encouraging support for research to find treatments and a cure for PKD.
Promoting education on the disease, its health and financial impacts, and the importance of regular medical visits.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_699
Sponsor: Rep. Cleaver, Emanuel [D-MO-5]
Process start date: 2025-09-11
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of September 2025 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_699.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-11.

What are the main provisions?

Key points include:

  • Raising public awareness about Polycystic Kidney Disease (PKD), a leading cause of kidney failure.
  • Encouraging support for research to find treatments and a cure for PKD.
  • Promoting education on the disease, its health and financial impacts, and the importance of regular medical visits.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Cleaver, Emanuel [D-MO-5].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-21.

CATEGORIES

Health